457 related articles for article (PubMed ID: 7860760)
21. Clinical aspects of plasma platelet-activating factor-acetylhydrolase.
Karasawa K
Biochim Biophys Acta; 2006 Nov; 1761(11):1359-72. PubMed ID: 17049457
[TBL] [Abstract][Full Text] [Related]
22. Oxidized LDL and HDL: antagonists in atherothrombosis.
Mertens A; Holvoet P
FASEB J; 2001 Oct; 15(12):2073-84. PubMed ID: 11641234
[TBL] [Abstract][Full Text] [Related]
23. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor.
Stafforini DM; McIntyre TM; Carter ME; Prescott SM
J Biol Chem; 1987 Mar; 262(9):4215-22. PubMed ID: 3549727
[TBL] [Abstract][Full Text] [Related]
24. Local expression of platelet-activating factor-acetylhydrolase reduces accumulation of oxidized lipoproteins and inhibits inflammation, shear stress-induced thrombosis, and neointima formation in balloon-injured carotid arteries in nonhyperlipidemic rabbits.
Arakawa H; Qian JY; Baatar D; Karasawa K; Asada Y; Sasaguri Y; Miller ER; Witztum JL; Ueno H
Circulation; 2005 Jun; 111(24):3302-9. PubMed ID: 15956136
[TBL] [Abstract][Full Text] [Related]
25. PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.
Karabina SA; Elisaf MC; Goudevenos J; Siamopoulos KC; Sideris D; Tselepis AD
Atherosclerosis; 1996 Aug; 125(1):121-34. PubMed ID: 8831934
[TBL] [Abstract][Full Text] [Related]
26. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma.
Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162
[TBL] [Abstract][Full Text] [Related]
27. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.
Tsoukatos DC; Arborati M; Liapikos T; Clay KL; Murphy RC; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3505-12. PubMed ID: 9437199
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.
Häkkinen T; Luoma JS; Hiltunen MO; Macphee CH; Milliner KJ; Patel L; Rice SQ; Tew DG; Karkola K; Ylä-Herttuala S
Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2909-17. PubMed ID: 10591668
[TBL] [Abstract][Full Text] [Related]
29. Platelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction.
Benítez S; Sánchez-Quesada JL; Ribas V; Jorba O; Blanco-Vaca F; González-Sastre F; Ordóñez-Llanos J
Circulation; 2003 Jul; 108(1):92-6. PubMed ID: 12821559
[TBL] [Abstract][Full Text] [Related]
30. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
Navab M; Hama SY; Anantharamaiah GM; Hassan K; Hough GP; Watson AD; Reddy ST; Sevanian A; Fonarow GC; Fogelman AM
J Lipid Res; 2000 Sep; 41(9):1495-508. PubMed ID: 10974057
[TBL] [Abstract][Full Text] [Related]
31. High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.
Satoh K; Imaizumi T; Yoshida H; Takamatsu S
J Lab Clin Med; 1994 Feb; 123(2):225-31. PubMed ID: 8301198
[TBL] [Abstract][Full Text] [Related]
32. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
Subramanian VS; Goyal J; Miwa M; Sugatami J; Akiyama M; Liu M; Subbaiah PV
Biochim Biophys Acta; 1999 Jul; 1439(1):95-109. PubMed ID: 10395969
[TBL] [Abstract][Full Text] [Related]
33. Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Khovidhunkit W; Memon RA; Shigenaga JK; Pang M; Schambelan M; Mulligan K; Feingold KR; Grunfeld C
Metabolism; 1999 Dec; 48(12):1524-31. PubMed ID: 10599983
[TBL] [Abstract][Full Text] [Related]
34. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.
Heery JM; Kozak M; Stafforini DM; Jones DA; Zimmerman GA; McIntyre TM; Prescott SM
J Clin Invest; 1995 Nov; 96(5):2322-30. PubMed ID: 7593619
[TBL] [Abstract][Full Text] [Related]
35. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
[TBL] [Abstract][Full Text] [Related]
36. LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.
Schnitzer E; Pinchuk I; Fainaru M; Lichtenberg D; Yedgar S
Free Radic Biol Med; 1998 May; 24(7-8):1294-303. PubMed ID: 9626586
[TBL] [Abstract][Full Text] [Related]
37. Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect.
Milionis HJ; Tambaki AP; Kanioglou CN; Elisaf MS; Tselepis AD; Tsatsoulis A
Thyroid; 2005 May; 15(5):455-60. PubMed ID: 15929667
[TBL] [Abstract][Full Text] [Related]
38. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.
Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Goudevenos JA; Chapman MJ; Elisaf M; Tselepis AD
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):306-11. PubMed ID: 11834533
[TBL] [Abstract][Full Text] [Related]
39. Lipoproteins alter the catalytic behavior of the platelet-activating factor acetylhydrolase in human plasma.
Stafforini DM; Carter ME; Zimmerman GA; McIntyre TM; Prescott SM
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2393-7. PubMed ID: 2928339
[TBL] [Abstract][Full Text] [Related]
40. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein.
Stafforini DM; Tjoelker LW; McCormick SP; Vaitkus D; McIntyre TM; Gray PW; Young SG; Prescott SM
J Biol Chem; 1999 Mar; 274(11):7018-24. PubMed ID: 10066756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
